189 related articles for article (PubMed ID: 32908225)
1. Inhibition of purinergic P2X receptor 7 (P2X7R) decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) expression in U251 glioblastoma cells.
Drill M; Powell KL; Kan LK; Jones NC; O'Brien TJ; Hamilton JA; Monif M
Sci Rep; 2020 Sep; 10(1):14844. PubMed ID: 32908225
[TBL] [Abstract][Full Text] [Related]
2. P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
Kan LK; Seneviratne S; Drummond KJ; Williams DA; O'Brien TJ; Monif M
Purinergic Signal; 2020 Sep; 16(3):327-336. PubMed ID: 32583309
[TBL] [Abstract][Full Text] [Related]
3. P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastoma.
Kan LK; Drill M; Jayakrishnan PC; Sequeira RP; Galea E; Todaro M; Sanfilippo PG; Hunn M; Williams DA; O'Brien TJ; Drummond KJ; Monif M
Sci Rep; 2023 May; 13(1):8435. PubMed ID: 37225786
[TBL] [Abstract][Full Text] [Related]
4. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
Giannuzzo A; Saccomano M; Napp J; Ellegaard M; Alves F; Novak I
Int J Cancer; 2016 Dec; 139(11):2540-52. PubMed ID: 27513892
[TBL] [Abstract][Full Text] [Related]
5. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
Giannuzzo A; Pedersen SF; Novak I
Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
[TBL] [Abstract][Full Text] [Related]
6. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
Allsopp RC; Dayl S; Schmid R; Evans RJ
Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas.
Revoltella RP; Menicagli M; Campani D
Cytokine; 2012 Mar; 57(3):347-59. PubMed ID: 22200506
[TBL] [Abstract][Full Text] [Related]
8. Roles of purinergic P2X
McLarnon JG
Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
[TBL] [Abstract][Full Text] [Related]
9. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity.
Zhao Y; Chen X; He C; Gao G; Chen Z; Du J
Bioorg Med Chem Lett; 2021 Nov; 51():128361. PubMed ID: 34543755
[TBL] [Abstract][Full Text] [Related]
10. The P2X7 receptor and Pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF.
Lemaire I; Falzoni S; Zhang B; Pellegatti P; Di Virgilio F
J Immunol; 2011 Oct; 187(7):3878-87. PubMed ID: 21865551
[TBL] [Abstract][Full Text] [Related]
11. P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway.
Fang J; Chen X; Zhang L; Chen J; Liang Y; Li X; Xiang J; Wang L; Guo G; Zhang B; Zhang W
Int J Biochem Cell Biol; 2013 Jun; 45(6):1109-20. PubMed ID: 23523696
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.
Kwak SH; Shin S; Lee JH; Shim JK; Kim M; Lee SD; Lee A; Bae J; Park JH; Abdelrahman A; Müller CE; Cho SK; Kang SG; Bae MA; Yang JY; Ko H; Goddard WA; Kim YC
Eur J Med Chem; 2018 May; 151():462-481. PubMed ID: 29649742
[TBL] [Abstract][Full Text] [Related]
13. Human glioblastoma cells produce granulocyte-macrophage colony-stimulating factor in vitro, but not in vivo, without expressing its receptor.
Murata J; Sawamura Y; Tada M; Sakuma S; Sudo M; Aida T; Abe H
Neurol Med Chir (Tokyo); 1993 Sep; 33(9):603-9. PubMed ID: 7505398
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells.
Ziberi S; Zuccarini M; Carluccio M; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Di Iorio P; Ciccarelli R
Cells; 2019 Dec; 9(1):. PubMed ID: 31905754
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M; Jones NC; Hunn M; O'Brien TJ; Monif M
Purinergic Signal; 2021 Jun; 17(2):215-227. PubMed ID: 33728582
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
17. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
[TBL] [Abstract][Full Text] [Related]
18. P2X7 targeting inhibits growth of human mesothelioma.
Amoroso F; Salaro E; Falzoni S; Chiozzi P; Giuliani AL; Cavallesco G; Maniscalco P; Puozzo A; Bononi I; Martini F; Tognon M; Di Virgilio F
Oncotarget; 2016 Aug; 7(31):49664-49676. PubMed ID: 27391069
[TBL] [Abstract][Full Text] [Related]
19. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
20. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression.
Mueller MM; Herold-Mende CC; Riede D; Lange M; Steiner HH; Fusenig NE
Am J Pathol; 1999 Nov; 155(5):1557-67. PubMed ID: 10550313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]